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Abstract 
Bone regeneration using degradable scaffolds gives clinicians an alternative approach to 
the repair of damaged tissue while avoiding the need for a permanent implant. The 
composition of the scaffold material is vital to the success of bone regeneration. The 
scaffold material used should display biocompatibility, degradability, mechanical 
integrity, and osteoconductivity. Scaffolds used in this study were made by the melt 
molding/particulate leaching technique . The synthetic polymer, poly(DL-lactic-co-
glycolic acid) (PLGA) was used in this study to construct the three dimensional porous 
scaffolds. This provided the mechanical integrity for scaffold. Bioactive inorganic 
element (BIE) was incorporated into the scaffold to promote osteogenesis. NaCl was 
used as a water soluble porogen to create porosities. The objective of this study was to 
characterize the mechanical strength and solubility of scaffolds with different 
compositions of PLGNBIE with varying porosities. Scaffolds were made into cylinders 
5mm in diameter by 5mm in height. Compressive strength of the scaffolds was tested 
using an Instron Universal Testing Machine using the femur bone of rabbits with similar 
dimensions as controls. Solubility of silicon was tested by electron dispersed x-ray 
anlysis of scaffolds and Fourier Transforming Infrared Spectroscopy of culture medium 
used in the incubation of the scaffolds at 37°C. Results of compressive strength test 
indicate that scaffolds with at least 60% PLGA by weight and with no more than 50% 
porosity has comparable compressive strength to rabbit bone. Scaffolds with more BIE 
released more silicon as measured by SiOH bond compared to scaffolds with less BIE. 
Scaffolds with 50% porosity and 50% bioactive inorganic element showed up to 56.6 mg 
of silicon released into culture medium by 28 days. 
X 
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INTRODUCTION 
Presently there is an increasing demand for improved techniques to regenerate or 
engineer bone in both the medical field as well as the dental field. There are over 
1,000,000 cases of skeletal deficiencies reported each year (Langer et al., 1993). Bone 
loss can result from trauma, tumors, congenital abnormalities, and other bone diseases. 
Most of these cases require skeletal reconstruction, often in the form of grafts. Currently, 
autografts, allografts, and various types of synthetic materials are the most commonly 
used grafting materials. Of these materials, autogenous grafts are the most successful due 
to the transplantation of bone containing live cells and bioactive molecules (Shaffer, J.W. 
et. al., 1985). The graft contains viable cells that are osteoconductive, osteoinductive, 
and promote osteogenesis. However, its supply is limited and requires traumatic 
harvesting procedures that can cause donor site morbidity and contour irregularities. 
Allografts have shown some success, but it has the potential of transferring pathogens 
and causing a cell mediated immune response (Goldberg, V .M. et. al., 1987). Synthetic 
substitutes may cause stress shielding to the surrounding bone or fatigue failure of the 
substitute. 
In the oral cavity , bacterial infection of the root canal system can progress to infection 
and resorption of the periradicular system. This leads to the formation of apical 
periodontitis and subsequent bone resorption. A recent study showed that out of a 122 
teeth examined after initial (first-time) endodontic treatment for "healed" (no apical 
periodontitis [AP], signs, symptoms) or "diseased" (AP, signs, or symptoms), 79% of 
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cases was considered healed when preoperative AP was present (Farzaneh M et al, 2004 ). 
The multidisciplinary field of tissue engineering offer new hope in finding an alternative 
approach to bone repair through use of the principles of engineering to develop biological 
substitutes to restore and improve tissue function and structure (Langer et al., 1993). 
Currently, there are three different approaches used to create new bone tissue. The first 
incorporates a conductive approach. The synthetic scaffold material is implanted into the 
bone defect and only allows the conduction of the desirable cell types and blocks the 
conduction of unwanted ones. In the second approach, bioactive materials such as 
growth factors are combined with the synthetic scaffold. The third approach allows the 
seeding of certain cells into the scaffold in vitro followed by implantation of the cell-
scaffold complex (Murphy et al., 1999). This approach eliminates the chance of 
immunological rejection (Langer, et al., 1993; Ugo et al., 1997). 
The composition of the scaffold material is vital to the success of bone regeneration. The 
scaffold material used should display biocompatibility, degradability, mechanical 
integrity, and osteoconductivity (Murphy, W.L., et al., 2002). The physical properties of 
the material play an important role in creating the geometry of the scaffold. These 
properties include high surface area/volume ratio, mechanical and structural integrity, and 
openings or channels to allow vascular and neural infiltration (Putnam et al., 1996). The 
scaffold material also needs to have adequate space for cell distribution. High porosity in 
a scaffold material will provide the necessary space and surface for cell distribution. 
Ideally, the implanted scaffold should degrade at the same rate as new bone deposition. 
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Synthetic polymers are commonly used to construct the three dimensional porous 
scaffolds. Some commonly used polymers include poly(a-hydroxy acids), 
polydioxanone, polycaprolactone, and polyorthoesthers. The most widely used 
degradable polymers used as implants are poly(a-hydroxy acids), such as poly(lactic 
acid), poly(glycolic acid), and poly(DL-lactic-co-glycolic acid) (Gilding et al., 1981). 
They are mechanically strong and can be easily processed into desired three dimensional 
shapes. Their degradation rate can be manipulated by controlling the crystallinity, 
molecular weight, and copolymer ratio of lactic acid to glycolic acid (Chen, G. et al., 
2001). One of the disadvantages of poly(a-hydroxy acids) is that it is not 
osteoconductive. It is biocompatible but it does not promote osteogenesis. Used alone, it 
does not satisfy all the requirements of a good scaffold. 
It has been well documented that bioactive glass, a synthetic ceramic graft material, can 
promote osteogenesis . A glass is termed bioactive when it can form a bond to living 
bone (Hench, L.L. et al., 1973). This occurs through a series of chemical reactions 
occurring at the surface of a bioactive glass that is exposed to body fluids and leads to the 
formation of a surface layer of hydroxycarbonate apatite (HCA) (Ohtsuki, C. et al., 
1991). This HCA layer then becomes incorporated with collagen fibrils thereby forming 
a bond to the surrounding tissue (Hench, L.L. et al., 1993). However, bioactive glasses 
are very brittle, which limits their use in load bearing applications (Wang, M. et al., 
1998). 
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In this study, a porous scaffolding matrix composed of poly(a-hydroxy acids), 
specifically poly(DL-lactic-co-glycolic acid) (PLGA), and bioactive inorganic element 
(BIE), a bioactive glass was constructed . The mechanical as well as the solubility 
properties of the matrix using different ratios of the PLGA to BIE with different 
porosities was tested. 
5 
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LITERATURE REVIEW 
Bone Maturation 
Like many tissues m the body, bone is composed of two elements, bone cells and 
extracellular matrix (ECM). Bone cells are derived from either mesenchymal orgin, such 
as osteoblast and osteocytes, or from hematopoietic orgin, such as osteoclasts. Even 
though these cells take up a very small portion of the total bone volume, they play critical 
roles in development and regulation of the mineralized matrix. 
Bone is composed of both organic and inorganic materials. Inorganic minerals include 
apatite or hydroxyapatite and constitute 67% of the bone matrix. The other 33 % is 
composed of organic matrix. 85% of the organic matrix is collagen fiber components, 
mostly collagen type I. The other 15% of the organic matrix is the ground substance and 
includes osteocalcin, osteonectin, osteopontin, bone morphogenetic proteins, bone 
proteoglycans and glycosaminoglycans, bone sialoproteins, and bone phosphoproteins. 
Osteoblast develops from preosteoblast and when they differentiate and proliferate they 
become osteocytes (Nijweide et al., 1986; Marks and Popoff, 1988). The main function 
of the osteoblast cell is to synthesize the organic matrix of bone. Osteoblast produce type 
I collagen, osteocalcin (Hauschka et al., 1989), osteopontin, and bone sialoprotein (Sodek 
et al., 1987). Once the ECM is mineralized, the osteoblast become embedded in the 
mineralized matrix and become osteocytes. The immobile osteocytes communicate with 
each other and the surrounding tissue through gap junctions and cytoplasmic extensions 
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(Sodek et al., 1987). 
Osteoclasts are primarily responsible for bone destruction and resorption. They are 
multinucleated cells which are characteristic of cells of the hematopoietic orgin such as 
macrophages. They have a ruffled border which can create a tight seal with adjacent 
bone. This tight bond plays an important role in resorption because the osteoclast pumps 
H+ ions in this area and cause resorption from the concentrated, acidic environment. 
Normally, formation and resorption of bone are coupled. That is, old bone is constantly 
being replaced by new bone. This rate of bone turnover decreases with age. It is 
regulated by the body through hormones such as parathyroid hormone and calcitonin 
(Huffer, W., 1988). 
Bone maturation occurs through two main methods. Flat bones of the skull, the sternum, 
and the scapula develop through intramembranous ossification. In this process, 
formation of bone is characterized by the absence of a cartilaginous model of the 
developing bone. Instead, maturation occurs first through formation of spongy bone, 
which contains a greater amount of loose connective tissue than bone, and then 
subsequent replacement with compact bone. Long bone of the ribs and limbs matures 
through endochondral ossification. This process is characterized by the presence of 
cartilaginous model of the developing bone. 
Lamellar bone is the dense, mineralized layer of bone. They are sometime referred to as 
cortical or compact bone. Within the lamellar bone, there is circumferential lamellae, 
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concentric lamellae, and interstitial lamellae. The circumferential lamellae form the outer 
perimeter that encloses the bone and is relatively avascular. The concentric lamellae 
forms the bulk bone and is composed of osteons, which are the basic metabolic unit of 
bone and are consequently relatively thick and vascular. The interstitial lamellae fill in 
the spaces between adjacent concentric lamellae and actually are residual fragments of 
pre-existing concentric lamellae which have undergone remodeling. 
The cancellous bone or spongy bone in our body is not as dense and mineralized as 
lamellar bone. They constitute the marrow spaces. Red marrow is primarily vascular and 
produces the red blood cells and white blood cells, whereas yellow marrow is primarily 
fatty. 
Bone Healing 
Bone healing occurs through callus formation. First the tissue debris and clotted blood at 
the fracture site are removed through invading neutrophils and macrophages. As new 
blood vessels invade the site, granulation tissue forms from newly formed connective 
tissue. Cartilage then develops in the granulation tissue and forms the callus that bridges 
and stabilizes the fracture. Osteoblasts from the surrounding periosteum and endosteum 
form a layer of bone on the callus. The cartilage of the callus is replaced by bone through 
endochondral ossification and the connective tissue is replaced by bone through 
intramembranous ossification. 
Scaffold 
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An ideal bone graft would simulate an autograft but without the associated problems such 
as donor site morbidity and limited supply of available tissue. Scaffolds are transitional 
physiochemical structures wherein the cells occupying it form replacement tissue as the 
scaffold itself degrades or becomes incorporated with the surrounding tissue. They can 
be seeded with a variety of cells such as chondrocytes for cartilage formation or 
osteoblasts for bone formation. There are a number of properties that define an ideal 
scaffold (Feinberg , S.E. et al., 2000). It should biodegradable, ideally at a rate that 
mirrors the rate of bone formation . It should also be non-toxic as well as have 
degradation products that are non-toxic. It should allow for cell attachment and also be 
able to be remodeled by the cells. It is important for the scaffold to possess the same 
strength, compliance, and density as the tissue it is replacing. The scaffold needs to have 
pores and channels to allow cell motility and the ingress of vascular elements. It should 
have a low level of immunogenicty as well as thrombogenicity. The scaffold should also 
have adequate strength to allow for fixation with screws or sutures if necessary. Finally, 
the scaffold should have interaction with the surrounding tissues. 
There are three general categories of scaffold design (Feinberg, S.E. et al., 2000). The 
first class of scaffolds is the non-bioabsorbable . These scaffolds are man made and 
include materials such as Dacron, Nylon, and polytetrafluroethylen (PTFE). These 
materials contain little or no information for the cells. The second class of scaffolds is 
bioabsorbable. The scaffolds in this group are man made and contain low degree of 
tissue information for cells. Examples of this group are the poly(a-hydroxy acids), such 
as polylactic acid (PLA), polyglycolic acid (PGA), and combinations of the two, 
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poly(DL-lactic-co-glycolic acid) (PLGA). Also included in this group are the calcium 
phosphate ceramics, hydroxyapatite (HA) and tricalcium phosphates (TCP). The third 
group of scaffolds is the naturally occurring materials. These contain a high degree of 
information for the cells and include biomatrix, animal and human tissues, or animal 
polymers. The polymers that are commonly used are collagen, elastin, larninin, 
fibronectin, and glycosaminogylcan . 
The internal architecture of a scaffold can affect bone regeneration in many ways. The 
size of the pores of the scaffold influences the diffusion pathways of nutrients to the cells 
(Feinberg, S.E et al., 2000). A more porous scaffold allows for greater diffusion of 
nutrients among cells in the scaffold and in the surrounding tissues. Increasing porosity of 
a scaffold increases its surface area/volume ratio. This increase in surface area allows for 
greater substrate area to support cell adhesion, growth, and proliferation. 
Channels created in the scaffolds increase cell and tissue penetration. They are intended 
to allow for development of vascular tissue by the in growth of granulation tissue from 
the host. The increase in vascularization in the scaffold allows for more transport of 
nutrients which is essential to the developing tissue. In addition, development of a single 
capillary permits Harvasian-type bone formation (Tsuruga et al., 1997). 
Tsuruga et al investigated the effects of pore size on osteon formation using ceramics of 
hydroxyapatite. They devised scaffolds made of hydroxyapatite and recombinant human 
BMP-2 with varying pore sizes, 106-212, 212-300, 300-400, 400-500, and 500-600. The 
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scaffolds were then implanted into the backs of mice. At 1, 2, 3, and 4 weeks post 
implantation, the implant and surrounding tissue were subject to biochemical and 
histological analysis. They found that scaffolds with pore size of 300-400 µm showed 
highest alkaline phosphatase activity and osteocalcin content. When pore size increased 
from 500-600 µm, there was no integrated bone formation along the inner walls. In 
addition, multiple large capillaries were found within a single pore. This was not 
observed for pores of 300-400 µm. They concluded that the ideal pore size for generation 
of osteogenesis is 300-400 µm (Tsuruga et al., 1997). 
The vasculatures created from channels are essential to osteogenesis because bone 
formation requires oxygen tension. In 2000 Jin noted that with low oxygen tension, 
chondrogenesis occurred in an in vitro culture system. Furthermore, when there was high 
oxygen tension, bone formed (Jin et al., 2000). 
Kuboki et al also showed that high oxygen tension is needed for bone formation . Their 
study compared scaffolds made with porous particles of hydroxyapatite (PPHAP) or 
fibrous glass membrane (FGM). This study also combined the scaffolds with BMP and 
subcutaneously implanted them into the backs of mice. At 1, 2, 3, and 4 weeks post 
implantation, the implants were subject to biochemical and histological analysis. 
Through enzyme-linked immunosorbent assay, they found that the type II collagen 
content in FGM/BMP was six times higher than their control of insoluble bone matrix. 
There was also no detectable type II collagen in the PPHAP/BMP implants. These 
results indicate that scaffold geometry that restrictes vascular invasion produce cartilage 
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and scaffolds that could accommodate a vascular invasion result in bone formation 
(Kuboki et al., 1995). 
Channels and pores have a direct affect on the mechanical behavior of the scaffold due to 
the decrease in scaffold density. The mechanical integrity of the scaffold material is 
crucial for the resistance of contractile cellular forces during tissue growth and 
development. Inadequate strength can result in collapse of the 3-dimensional structure of 
the scaffold. It is important to devise a scaffold system with shape memory so that 
clinicians can control the shape of the final tissue product (Murphy et al., 1999). 
Scaffolds are very important aspect of bone tissue engineering. Natural and synthetic 
materials have been used because of their biocompatibility, biodegradation, and 
mechanical strength. Several techniques have been described to create highly porous 
scaffolds. Some of the commonly used methods include fiber bonding, solvent 
casting/particulate leaching, gas forming, and phase separation. 
Fiber bonding produces highly porous PGA scaffolds with interconnected pores that can 
be used for tissue generation. Two different techniques have been developed in 
producing these scaffolds. The first technique developed by Mikos et al. in 1993, 
immersed PGA fiber in PLLA solution. The network of PGA fibers gets embedded in 
PLLA following evaporation of the solution. The complex is then heated until just above 
the melting point of PLLA. As the PLLA melts, it fills all the voids left by the PGA 
fibers while retaining the spatial arrangement of the fibers. Then the fibers are melted at 
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their cross points to minimize interfacial energy. Finally, PLLA is removed by 
dissolution with methylene chloride. The resulting scaffold can have porosities as high 
81 % and pore diameters of up to 500 µm. Scaffolds made in this manner showed that 
hepatocytes cultured for one week in these foams remained alive and began interacting 
with each other to form cultures (Mikos et al, 1994). 
The second method of bonding PGA fibers was developed by Mooney et al. He 
dissolved PLLA or PLGA in chloroform and sprayed the solution onto the fibers. Since 
PGA fibers are weakly soluble, the fibers stayed unchanged during this process. As the 
solvent evaporates, the PGA fibers are left glued together. Pore sizes comparable to 
previous techniques were reported (Mooney et al., 1996b). In vivo experiments done 
with tubes made in this method showed fibrous tissue growth. The scaffold was 
implanted in rats for 17 days. The results indicate that constructs made with these 
properties could encourage neotissue formation (Mooney et al., 1996b ). 
However, there are several disadvantages to fiber bonding. Both of these techniques 
involve the use of toxic solvents. It would be harmful to the cells if trace amounts of 
solvent remained. Therefore constructs would be vacuum dried for several hours which 
would make it difficult to use them immediately in a clinical setting. Additionally, the 
first method described by Mikos et al. heats the scaffold to extreme temperatures which 
would make it difficult to incorporate bioactive molecules such as growth factors. 
To eliminate the need for toxic solvents, a gas forming technique was developed. This 
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process uses gas a porogen to make pores. First, solid disks of PGA, PLLA, or PLGA 
made by compression molding are placed in a chamber and get exposed to high pressure 
CO2 (5.5 Mpa) for three days. Then the pressure is rapidly lowered to atmospheric 
pressure. Although this method eliminates the need for harsh chemical solvents, the use 
of high temperature in making the disks prohibits incorporation of bioactive molecules. 
Also, the unconnected pore structure makes cell seeding and migration within the 
scaffold difficult (Mooney et al., 1996a). 
In 2000, Nam and his colleagues developed another technique for using gas as a porogen. 
This method incorporates both gas foaming and particulate leaching aspects. Ammonium 
bicarbonate is added to a solution polymer in chloroform or methylene chloride resulting 
in a highly viscous mixture that can be shaped into three dimensional structures using 
molds. The solvent is then evaporated and the scaffold is either vacuum dried or 
immersed in warm water. Immersion in warm water results in porosities as high as 90% 
with pore sizes ranging from 200µm to 500µm (Nam et al., 2000). Nam et al. tested the 
scaffolds in vitro by seeding rat liver cells in culture. In one week, 40% of the cells 
remained viable which suggest that the scaffolds are biocompatible and allow for 
adequate nutrient exchange (Nam et al., 2000). 
Solvent casting/particulate leaching is another technique developed to create porous 
scaffolds. It involves the use of water soluble porogen such as salt (NaCl) to create 
pores. This technique allows the technician to control the degree of porosity by the 
amount of salt added and the size of the pores by controlling the size of the NaCl crystals. 
15 
A mixture of the polymer/salt composites are compression molded into cylindrical form 
at a temperature just above the melting point in the case of PLLA or the glass transition 
temperature in the case of PLGA. This method allows for more precise control of 
scaffold thickness and also increases the uniformity of the surface. Scaffolds developed 
with this technique have been extensively used with different cell types with no negative 
effects on tissue formation. However, researchers have showed concern about the 
thermal degradation of the polymer during the compression-molding step (Thomson et 
al., 1998; Goldstein et a., 1999). 
In the phase separation/emulsification technique, porosity is created through use of phase 
separation rather than incorporation of a porogen . This could be done with 
emulsification/freeze drying (Whang et al., 1995) or liquid-liquid phase separation (Lo et 
al., 1995). In the liquid-liquid phase separation technique is favorable because porosity 
and pore size can be controlled. Again, as in fiber bonding, the use of organic solvents 
precludes the incorporation of bioactive molecules. Additionally, the phase diagrams of 
the polymer-solvent systems must be better characterized before fully exploring the use 
of this method of scaffold construction in tissue engineering (Mikos et al., 2000). 
Poly(a-hydroxy acids) 
Poly(a-hydroxy acids) are thermoplastic aliphatic poly esters. Included in this group are 
poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and poly(DL-lactic-co-glycolic acid) 
(PLGA). They are by far the most used synthetic degradable polymers for resorbable 
drug delivery devices and implants (Gilding et al., 1981 ). They have been studied 
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extensively by researchers. 
PLA is commercially available as Dexon, a biodegradable suture. It is synthesized by a 
cationic ring polymerization of lactide, the cyclic diester of lactic acid. PLA can be 
produced in the L-, D-, and racernic DL-forms as lactic acid is optically active and has an 
asymmetric carbon. L-PLA is sernicrystalline in nature due to high regularity of its 
polymer chain. It has a glass transition temperature of 50-60°C and a melting point of 
around 180°C. It is soluble in chloroform and ct-methylene chloride. DL-PLA is 
amorphous due to its irregularities in its polymer chain structure. It has a glass transition 
temperature of 50-60°C but unlike L-PLA, it is soluble in most organic solvents including 
acetone, benzene, chloroform, dioxane, ethyl acetate, and methylene (Juni et al., 1987). 
PGA is synthesized by ring opening polymerization of glycosides. It is highly crystalline 
because it lacks the methyl side groups of the PLA. It has a glass transition temperature 
of 360°C and a melting point of 223-227°C. It is only soluble in hexafluoroisopropanol , 
phenol-trichloropheno, and hexafluoroacetone. 
DL-lactic and glycolic acids can be mixed together to form a copolymer, poly(DL-lactic-
co-glycolic acid) (PLGA), to enhance the desirable attributes of each monomer. 
Together, they have a normal crystallinity of around 37% to 50%. When in a copolymer 
state, the crystallinity decreases linearly with an increase of either component. PLA is 
more hydrophobic than PGA since it has a methyl group instead of a hydrogen group. 
The degree of hydrophillicity determines the rate of degradation since there is more water 
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uptake (Juni et al., 1987). Therefore, the degradation period can be manipulated by 
controlling the ratio of lactic to glycolic acid. This can be used to develop a scaffold that 
degrades at a rate which parallels osteoblast proliferation and allows for sufficient bone 
matrix secretion to withstand local stresses . 
PLGA degrades by cleavage of its backbone ester linkages (Jain 2000) into lactic and 
glycolic acids. The lactic acid enters the tricarboxylic acid cycle and is metabolized and 
eliminated from the body as carbon dioxide and water. The glycolic acid can be excreted 
unchanged in the kidney or is eliminated from the body as carbon dioxide and water in 
the same way as lactic acid. 
Poly(a-hydroxy acids) have been widely used as scaffolds because of their excellent 
properties . They are biocompatible and their degradation products are eliminated from 
the body either through the metabolic pathway or by direct renal excretion (Hollinger, 
J.O. et al., 1986). They can also be easily fabricated into any desired shape since they are 
very malleable (lshaug , SL et al. 1997). This gives clinician the potential of using them 
to fill in skeletal defects of various sizes and shapes. The Food and Drug Administration 
(FDA) approved their use as synthetic degradable polymers as resorbable sutures 
(Benicewicz BC et al., 1991) and drug carriers (Holland SJ et al., 1986). 
In 2000, Agrawal et al. tested the effects of fluid flow on the biodegradation kinetics of 
porous PLGA disks (Agrawal, CM et al, 2000). The disk were fabricated using a 50:50 
poly(DL-lactide-co-glycolide) copolymer ratio and processed by the solvent casting, 
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particulate leaching technique. They tested 3 different porosities, low, medium, and high 
and also tested the effects of fluid flow. The disks were placed in phosphate buffered 
saline solution at 37°C for up to 6 weeks under static conditions or under a constant fluid 
flow environment. At different time points the disk were removed and the mass was 
recorded and the permeability, porosity, and mechanical properties were evaluated. They 
found that scaffolds with lower porosity and permeability degraded faster than the 
scaffolds with higher porosity and permeability. Additionally, they found that a fluid 
flow environment decreased the rate of degradation significantly. They concluded that at 
constant conditions, the acidic degradation products assisted the autocatalysis of the 
degradation reaction. 
In that same year Lu et al. also tested the degradation of PLGA porous foams (Lu et al., 
2000a). They tested two different PLGA copolymer ratios, 85: 15 and 50:50, with 
varying porosity and varying pore sizes. They used a solvent casting, particulate leaching 
technique to produce porous PLGA disks. The in vitro test was done in phosphate 
buffered saline at 37 °C on a shaker table for us to 20 weeks. For the in vivo tests, they 
implanted the PLGA disk into rat mesentery. Their data indicate that the copolymer ratio 
of 50:50 significantly increased degradation both in vitro and in vivo as indicated by the 
accelerated weight loss. This was due to the higher content of hydrophilic glycolic acid 
units in PLGA 50:50 foams which this facilitated the absorption and diffusion of water 
and thus the hydrolysis of the ester bonds. Additionally, they found that the degradation 
rate of PLGA foams was found to be independent of their pore morphology during the 20 
weeks. The half lives of the PLGA 50:50 foams during in vitro degradation were 
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approximately 3 weeks , significantly less than that of the 12 weeks for the 85: 15 foams. 
Similar results were found under in vivo conditions with a shorter half-life of about 2 
weeks for PLGA 50:50 as compared to 12 weeks for 85: 15 foams. 
Lu et al conducted similar experiments with poly(L-lactic acid), PLLA foams to test the 
effects of pore size and porosity on degradation (Lu et al., 2000b ). Four types of foams 
were fabricated, three with initial salt weight fraction of 70, 80, and 90% using salt 
particles from 106-150 µm, and one with 90 % initial salt weight fraction using salt 
particles from 0-53 µm. They tested their foams in phosphate-buffered saline at pH 7.4, 
at 37 °C for 46 weeks . After their respective time periods, the foams were dried, 
weighed, and tested for porosity, pore distribution and mechanical properties . They 
found that the degradation of PLLA foams were independent of pore morphology with 
insignificant variation in foam weight, thickness, pore distribution, compressive creep 
behavior, and morphology during degradation. The half-lives of the foams ranged from 
11.6 weeks (70%) to 43 weeks (90% ). Their findings indicate that the thicker pore walls 
for foams with 70 or 80% salt weight fraction as compared with those with 90% salt 
weight fraction contributed to an autocatalytic effect resulting in faster foam degradation. 
In addition, foams prepared with 0-53 µm salt particles had an increased pore 
surface/volume ratio which enhanced the release of degradation products thus 
diminishing the autocatalytic effect and resulting in slower foam degradation compared 
with foams fabricated with larger salt particles. 
Murphy et al tested the ability of porous PLGA scaffolds to form bonelike minerals in 
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simulated body fluid (Murphy et al, 1999). They fabricated scaffolds using a solvent 
casting/particulate leaching technique and analyzed mineral formation through FITR and 
SEM analysis after incubating scaffolds in SBF solution for up to 14 days. Their results 
indicate the growth of a continuous bonelike apatite layer within the pores of the polymer 
scaffolds. 
In 2002, Borden et al found that cellular proliferation penetrated into scaffolds 
approximately 700 um from the surface (Borden et al, 2002). They constructed 50:50 
PLGA scaffolds using a sintering technique based on microsphere technology creating 
pore sizes ranging from 100-250 um. They tested their scaffolds by seeded either rat 
osteoblast or fibroblast for 14 days of cell culture. They found that PLGA scaffolds 
demonstrated excellent cellular attachment and proliferation throughout the matrix. 
Puelacher et al. did a study in 1994 using PLA and PGA scaffolds (Puelacher et al., 
1994). He implanted PLA and PGA scaffolds subcutaneously into nude mice with and 
without chondrocyte pretreatment. After eight weeks, the scaffolds with pretreated cells 
showed cartilage formation . This is evidence that PLA and PGA are not only 
biocompatible but also promote cell proliferation and growth. 
In 1993 Freed et al. did an in vitro study with cultured chondrocytes on fibrous 
polyglycolic acid (PGA) and porous poly(L)lactic acid (PLLA). The chondrocytes were 
isolated from bovine or human articular and costal cartilage . They found that the cell 
growth rate on the PGA was twice as high as on the PLLA. Additionally, cells grown on 
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PGA produced sulfated glycosaminoglycan (S-GAG), a cartilage matrix, at a high steady 
rate and cells grown on the PLLA produced only minimal amount of S-GAG. They 
concluded that these differences were due to the geometry of the polymers and their 
degradation rate (Freed et al., 1993). 
In 1997, Grande et al. evaluated different matrixes for tissue engineering of articular 
cartilage grafts (Grande et al. 1997). They seeded fresh articular samples isolated from 
bovine ankle joints into PGA scaffolds and a collagen matrix scaffold for three weeks in 
closed culture recirculating system for three weeks. They found that chondrocytes 
cultured on PGA had enhanced proteoglycan synthesis whereas collagen matrices 
stimulated synthesis of collagen. 
In studies done on implantation of PGA or PLA rods, a late inflammatory reaction occurs 
due to the release of glycolic and lactic acid (Bostman, O.M. et al, 1990). In the 
immediate period following implantation, the patient had no local or systemic signs of a 
problem. However, this period was followed by a painful, erythematous, fluctuant 
swelling. 
Fu et al. confirmed the results of Bostman when he showed that degradation of PLGA 
particles form an acidic environment, with a pH as low as 1.5 (Fu et al, 2000). They were 
able to visualize the spatial and temporal distribution of pH degrading microspheres using 
pH sensitive fluorescent dyes and confocal fluorescence microscopy. They found that the 
center of the spheres had the most acidic environment and gradually increased towards 
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the edge. This observation is characteristic of diffusion-controlled release of acidic 
degrading products. This may be of concern to clinicians using this product in the 
development of devices for drug delivery. 
A study done by Hsu et al. in 1997 showed that the density of five different polymers, 
PLLA, PGA, PLGA, poly(g-benzyl-L-glutamate) (PBLG) , and poly(propylene fumarate) 
(PPF), correlates with the release rate or degradation rate of the polymers. They 
incorporated Isoniazid (INH) into the polymer foam and immersed the foams into 
phosphate-buffered saline (PBS) solution. INH content was analyzed using a Cary 1 
spectrophotometer. Their results indicate that lower density foams release INH more 
rapidly than higher density foams. They concluded that low molecular weight polymers 
releases ions faster that those with a higher crystallinity and that the release mechanism 
of the foam matrices is lattice diffusion controlled (Hsu, Y. Y. et al., 1997). 
Ishaug, S.L. et al. have shown that different ratios of PLGA films have the ability to 
support osteoblast attachment, growth, and function (lshaug, S.L. et al., 1994). Rat 
osteoblast cells were cultured on films of poly (L-lactic acid) (PLLA) , 75:25 PLGA, 
50:50 PLGA, and poly(glycolic acid) (PGA). In their study, they found more than 100% 
attachment of osteoblast on PLGA relative to tissue culture polystyrene control substrate. 
By day 4 in culture, the osteoblast reached confluency and their proliferation rate leveled 
off by day 7. They also found that the cells produced similar amounts of collagen. In 
addition, they found that the morphology of cultured osteoblast did not change even with 
the continuous degradation of the polymer substrate. Interestingly, only the 75:25 
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combination of PLGA produced a comparable amount of increase of alkaline 
phosphatase as control. The ALP level increased from 1.92 (+/- 0.47) x 10-7 for day 7 to 
5.75 (+/- 0.12) x 10-7 µmol/cell per min for day 14. Bone cells have been shown to 
produce more alkaline phosphatase and other markers of osteoblastic phenotype as 
replication slowed down (Aubin, J.E. et al., 1992). 
Laurencni et al tested osteoblast cells for their ability to maintain their phenotypic 
properties for a period of 24 days on scaffolds (Laurencni et al., 1996). Osteoblasts from 
rat calvaria were cultured with mixture of PLGA and hydroxyapatite (HA). Results were 
similar to the study done by Ishuag et al. Cell attachment and proliferation increased 
during the first 14 days followed by a period of gradual plateauing of cell numbers . No 
mineralization was detected in the cell free mixtures or in the samples without beta-
gl ycerophospate. 
Recently, a study successfully implanted PGLA scaffolds seeded with osteoblasts cells in 
rabbit osteotomy (Holy, C.E. et al, 2003) . PGLA 75/25 scaffolds with geometry similar 
to that of trabecular bone were seeded with 7 .5 x 105 cells. New bone tissue was evident 
throughout the scaffold volume and to a depth of 10 mm after 8 weeks. There was no 
observed inflammatory response as commonly seen with PGLA degradation. The 
investigators believed that the macroporous geometry of the scaffolds allowed rapid 
diffusion of acidic products and rapid invasion of host vascular tissue, thereby avoiding a 
concentrated acidic environment. 
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Bioceramics 
In 1998, Hench classified bioceramics into four groups based on their tissue attachment 
ability (Hench, L.L., 1998). The first class includes alumina (A}i03) zirconia (Zr0 2) and 
either need cement or pressure for bonding or need to be press fitted into the defect. 
These materials are bioinert. The second class consists of porous implants composed of 
hydroxyapatite (HA) and HA coated porous metals . These materials mechanically attach 
to bone through bony ingrowth into the porous material . The third class is the resorbable 
materials . These include tricalcium phosphate, calcium sulfate (plaster of paris) , and 
calcium phosphate salts. They can attach to bone and slowly get resorbed. The last class 
is the surface reactive ceramics. These are composed of dense hydroxyapatite, bioactive 
glasses, and glass ceramics . They attach directly to bone through chemical binding . 
Bioactive Glasses 
Bioactive glasses are glasses that have the ability to bond to living bone (Hench, L.L., 
1973). To achieve this bonding , a number of chemical compounds are required. Theses 
include P2O5, Na2O, SiO2, and CaO. Research has shown that the material is 
biocompatible and nontoxic (Wilson, J. 1981 ). It also does not cause inflammation and 
does not prevent cell division and growth in culture. This property makes them very 
useful for biomedical and surgical purposes . 
Bioactive glasses are divided into two classes. Class A glass has osteoproductive activity 
due to both intracellular and extracellular factors. Wilson defines osteoproduction as "the 
process whereby a bioactive surface is colonized by osteogenic stem cells free in the 
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defect environment as a result of surgical intervention" (Wilson, et al., 1992). The 
intracellular effect of this class of bioactive glass is a result of silicon release . Soluble 
silicon is released by both ion exchange and network dissolution. It has been shown that 
soluble silicon can be used to regulate growth factor proteins and enhance bone growth 
(Xynos, I.D. et al., 2000). Class A bioactive materials form hydrated silica gel and a 
HCA layer. This results in nanometer scale porosity. The silica gel layer usually forms 
within minutes of being exposed to body fluids. This high surface area and nanometer 
scale porosity induces the extracellular effect of chemisorption of bone growth proteins, 
such as TGF-~1 on the implant surface (Hench, L.L., 1994). 
Class B glasses are only osteoconductive and include A-W glass-ceramic and synthetic 
hydroxyapatite. They provide a biocompatible interface along the bone margins. 
Bioactivity occurs where an extracellular response is elicited at its interface. There is low 
or zero rates of ion exchange with low rates of network dissolution. This class also 
releases insignificant or zero amounts of soluble silicon (Hench, L.L., 1994). 
In class A bioactive glass there is a very specific biological response at the interface of 
the material when implanted in bone. This bond has been related to the formation of a 
biologically active hydroxycarbonate apatite layer (HCA) on the surface of the glasses. 
Additionally, the apatite layer attracts osteoprogenitor cells and osteoblasts, thus 
stimulating bone formation. There are 12 stages of interfacial reactions involved in 
forming the bond between tissue and bioactive glass (Hench, L.L., 1993). 
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In the first stage, there is rapid exchange of cations such as Na+ or Ca2+ with H+ or H3O+ 
from solution leading to the formation of silanol (Si-OH): 
Si-O-Na+ + H+ + Off - Si-OH+ Na++ Off 
In stage two, there is the break up of the silica network (Si-O-Si) and the continued 
formation of silanols at the glass solution interface: 
2(Si-O-Si) + H20 = Si-OH+ OH-Si 
In stage three, there is condensation and repolymerzation of a SiO2 rich layer on the 
surface deleted in alkali and alkaline earth cations: 
Si-OH+ OH-Si= -Si-O-Si- + H2O 
In stage four, there is migration of Ca2+ and POl group to the surface forming CaO-PO 
rich film on top of the SiO2 rich layer. In stage five, there is crystallization of the 
amorphous film by incorporation of Off and co/- anions from solution to form a mixed 
hydroxyl carbonate apatite (HCA) layer. In stage six, there is adsorption and desorption 
of biological growth factors in the HCA layer to activate differentiation of stem cells. In 
stage seven, macrophages remove debris from site allowing cells to occupy the space. In 
stage eight, stem cells attach to bioactive surface. In stage nine, the stem cells 
differentiate to bone growing cells, such as osteoblasts. In stage ten, the osteoblasts 
produce extracellular matrix. In stage eleven and twelve, the inorganic calcium 
phosphate matrix crystallize to enclose bone cells in a living composite structure. 
Hench and LaTorre compared the rate of HCAp formation of 22 glass compositions in a 
Tris buffer solution with experimentally determined tissue response. In composition with 
less than 53 mol% SiO2, an HCAp layer formed within 3 hours and formed a bond to 
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both hard and soft tissue. For glasses with 53-56 mol% SiO2, it took 2-3 days to form an 
HCAp layer and bond to bone but not soft tissue. When SiO2 content increased to greater 
than 60 mol%, there was no formation of HCAp layer or bonding to bone or soft tissue. 
They concluded that there is a correlation between the rates of HCAp formation in vitro 
with tissue response in vivo (Hench, L.L. and LaTorre, G.P., 1992). 
Raether et al tested hydroxyapatite formation for PDLLA foams coated with Bioglass® 
using a slurry dipping technique in simulated body fluid (SBF) (Raether et al, 2002). 
Their technique produced stable homogenous Bioglass® coatings on the surface of the 
PDLLA foams as well as infiltration of the Bioglass® particles throughout the porous 
network. They incubated their scaffolds in 75ml SBF solution at 37°C, rotating at 175 
rpm for 7 to 28 days. They found that hydorxyapatite formed on the Bioglass® surface 
and that they layer thickness rapidly increased with increasing time in SBF. 
In 1993, Filgueiras et al. investigated the relationship between reaction time and silicon 
composition in simulated body fluid (SBF) (Filgueiras, M.R. et al, 1993a). When silicon 
content was increased up to 52 wt%, the rate of reactions in stages 1-3 showed no 
significant effects. However, the calcium and phosphate ions in the SBF accelerated the 
production of an amorphous calcium-phosphate (a-CP) layer in stage 4 and the 
crystallization of the hydroxycarbonate apatite (HCAp) layer in stage 5. When the silicon 
content was increased up to 69 wt%, silica repolymerization in stage 3 was greatly 
retarded and crystallization of the HCA layer from the amorphous-calcium phosphate 
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was also inhibited. These results confirmed the importance of a Si-rich phase in the rapid 
crystallization of the HCA layer. 
Bosetti et al also tested the effect of silicon composition like Filgueiras but they used 
human primary osteoblast-like cells instead of simulated body fluid (Bosetti M et al, 
2003). The three materials they tested were 45S4 Bioglass®, which has a 46.1 % Si 0 2, 
58S sol-gel ioglass® , which has 60% SiO2 , and 77S sol-gel Bioglass®, which has 80% 
SiO2. They cultured lxl0 6 human osteoblast cells obtained from human trabecular bone 
on 1 mg/crn2 of the material powders. They found that 45S5 Bio glass was the highest 
inducer of collagen synthesis and produced higher alkaline phosphatase activity than in 
the control cultures and in the other bioactive glass cultures. 77S sol-gel Bioglas s® also 
induced high levels of collagen synthesis but had similar levels of alkaline phosphatase as 
control. 
In 2002, Sepulveda et al compared the in vitro dissolution of varying sizes of melt-
derived 45S5 and sol-gel derived 58S bioactive glasses in simulated body fluid and a-
MEM based cell culture medium (Sepulveda et al, 2002) . The 45S5 particles are non-
porous and consequently have low surface area. The 58S particles are highly porous (2-
50 nm pores) and have high surface area. They immersed the powder in the solutions for 
0.5, 1, 2, 4, 8, 17, and 22 hours at 37 C under dynamic conditions. At each time period 
they filtered the solutions and analyzed the concentration of the elements dissolved by 
inductively coupled plasma spectroscopy and evaluated the presence of hydroxyl-
carbonate apatite layer through Fourier transform infrared spectroscopy. They found that 
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Si content released deceases as particle size increases and that there was a higher 
concentration of Si release in simulated body fluid than cell culture medium for both 
bioactive glasses. They also found that the 45S5 glass powders exhibit lower dissolution 
rates and slower rate of apatite formation than the 58S gel-glass powders. This difference 
is attributed to the difference in texture between the two particles. 
Since most in vitro studies employ the use of simulated body fluid, Kaufmann et al 
wanted to test the effect of serum proteins in aqueous media on bioactive glass surface 
(Kaufmann et al, 2000). They incubated their bioactive glass disk with Dulbecco ' s 
Modiefied Eagle's minimum essential medium supplemented with 10% Nu-Serum, L-
glutamine , and penicillin/streptomycin and with simulated body fluid as a control. They 
found that the presence of serum proteins significantly delayed the formation of 
hydroxyapatite at the surface of the bioactive glass. 
In another in vitro study, Lu et al tested the ability of porous composite of PLGA and 
45S5 bioactive glass (BG) to support osteoblast adhesion, growth, and differentiation as 
well as test mechanical properties (Lu HH et al, 2003). They found that the addition of 
bioactive glass granules to the PLGA matrix resulted in a structure with higher 
compressive modulus than PLGA alone. In addition, they found that PLGA-BG 
composite formed a surface calcium phosphate deposits in both simulated body fluid and 
in the presence of human osteosarcom cells using surface analysis methods. Their 
composite scaffold stained positive for alkaline phosphatase and supported higher levels 
of Type I collagen synthesis than tissue culture polystyrene controls. 
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In 2000, Kaufmann et al found that in vitro cell activity can be controlled by careful 
selection of substrate properties (Kaufmann et al, 2000). They cultured ROS 17 /2.8 cells 
on bioactive glass with different porosity and pore size. When they tested scaffolds with 
an average pore size of 92 um, as they increased the porosity from 35 to 59%, they found 
that osteoblast activity was reduced. They concluded that with increasing porosity and 
surface area, glass reactions in the media may persist for longer durations at elevated 
intensities. They effect the local media composition and subsequently, the cells. 
Vrouwenvelder lead a study to determine the behavior of fetal rat osteoblasts cultured on 
four bone replacing materials: bioactive glass, hydroxylapatite, a titanium alloy, and 
stainless steel. They cultured osteoblasts on polished circular disk of the different 
material and examined for individual cell morphology and osteoblast expression. Their 
results reveal that osteoblasts cultured on bioactive glass showed better osteoblast-like 
morphology and higher proliferation rate leading to more confluent cultures with higher 
cell density than cultures on the other materials. In addition, they found that osteoblasts 
on bioactive glass displayed significantly higher alkaline phosphotase activity and DNA 
content. Based on their evaluation of the histological and biochemical parameter, they 
conclude that osteoblasts cultured on bioactive glass showed better osteoblast character 
than on the other materials (Vrouwenvelder, W.C.A. et al., 1993). 
In 1994, Vrouwenvelder et al. investigated the properties of four different bioactive 
glasses. He found that a small addition or subtraction of specific ions such as iron, 
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titanium, fluorine, or boron modified the basic 45S5 Bioglass network. His results show 
that proliferation rate and osteoblastic expression decreased in iron-doped cultures and 
was higher in titanium-doped cultures. In fluorine and boron-doped cultures, there was 
normal proliferation and moderate osteoblast expression (Vrouwenvelder et al., 1994). 
There have been many in vivo studies done to prove the properties of bioactive glass. A 
study was done with monkeys where periodontal defects were filled with Bioglass® 
particulates, hydroxylapatite particulates, or degradable tricalcium phosphate particulates 
(Wilson, J. et al., 1992). At nine months, results showed good osteoproduction of bone 
through osteoconduction from the alveolus and the inherent increase rate of formation of 
reaction layer of the Bioglass®. In addition, the superficial Bioglass® particles attached 
to collagen and restored the transeptal connection of the periodontium . They did not see 
this for the hydroxylapatite or tricalcium phosphate treated defects. In those sites, bone 
was only partially restored and instead of a normal peridontium, a long junctional 
epithelium was seen. 
In 1995, Heikkila et al. conducted a study using Bioglass to fill cancellous bone defects 
in rabbits. His results showed that there was no significant difference between Bioglass 
treated defects compared to autogenous bone filled defects. He noted that the new bone 
binds chemically to the implanted Bioglass particles through the formation of a silica-gel 
and calcium phosphate layer as shown by EDXA. In addition, the thickness of the 
reaction layer on the glass surface increased from 96 µm to 163 µm during the 12 week 
experimental period (Heikkila et al., 1995). 
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Wheeler et al. found that a narrower size range of bioactive glass particles do not have a 
positive effect on the regeneration of cancellous defects. They compared Bioglass, which 
has particles ranging from 90 to 710 µm, and BioGran, which has particles ranging from 
300 to 360 µm, with normal cancellous bone. They created 6-mrn sized defects of 
cancellous bone from the distal femoral metaphyses of rabbits and filled one side with the 
Bioglass and the other with the BioGran . Rabbits were euthanized 4 and 12 week post-
operatively for histological and biomechanical analysis. They found that the narrower 
particle range adversely affected the quantity of osteointegration because a large 
percentage the defect are was composed of bioactive glass or voids, whereas a larger 
percentage of the defect area was filled with bone in the Bioglass defects . In addition, the 
compressive modulus and stiffness of the BioGran material were reduced from those of 
normal bone and Bioglass filled defects, although the difference was not significant 
(Wheeler, D.L. et al., 1998). 
In another study performed on rabbits, Oonashi et al. compared 45S5 Bioglass with 
hydroxyapatite as a bone graft substitute in femoral defects. Defects treated with 
Bioglass were completely restored in 2 week. It took 12 weeks for the defects treated 
with hydroxyapatite to show similar restoration. In addition, the Bioglass particles were 
also easy to manipulate and stayed in place, whereas the hydroxyapatite particles tended 
not to stay in the bleeding site (Oonashi et al., 1997). 
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Wheeler et al. led an investigation in 1997 to show the effects of Bioglass® on rabbit 
radius ostectomy. Twenty mm unilateral ostectomies were either treated with Bioglass® 
or remained untreated in the control group. After 4 and 8 weeks, ostectomies were 
analyzed histomorphometrically and biomechanically. Results show that the Bioglass® 
group had more active mineralization throughout the ostectomy and that the limbs 
required more torque to break than the control. However, there was no significant 
difference between the two groups at 8 weeks. This study showed that bioactive glass 
may be useful to produce the early phase of osseous repair (Wheeler, D.L. et al., 1997). 
In 1997, Stanley et al. also evaluated the effectiveness of Bioglass on bone regeneration. 
He filled in the sockets of extracted teeth with Bioglass cones and found that at 5 years 
post insertion, Bioglass have a high retention rate (85%) (Stanley et al., 1997). 
Low et al. conducted a similar study that same year. He repaired periodontal osseous 
defects with Bioglass particles on 12 patients. His results showed significant 
improvements and patients were stable in 24 months (Low et al., 1997). 
34 
HYPOTHESIS 
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HYPOTHESIS OF THE STUDY: 
It is the hypothesis of this study that a composite that incorporates the ideal 
characteristics of a scaffold by maximizing the amount of bioactive inorganic element 
and using the least amount of PLGA for adequate strength can be used to successfully 
treat skeletal defects and will greatly increase treatment options for dental and medical 
clinicians 
The ideal characteristics seeked in this study are: 
1) Biocompatibility by using only biocompatible materials 
2) Using a polymer for mechanical strength to support function 
3) Silicone release for enhance bone growth 
4) Porosities to aid in cell and blood vessel in growth 
5) Porosities for nutrient and waste dispersal 
36 
OBJECTIVE 
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OBJECTIVE OF THE STUDY 
The objective of this study was to characterize the mechanical strength and solubility of 
scaffolds with different compositions of PLGNBIE with varying porosities 
The specific aims for this study are: 
1. Preparation of different compositions of cylindrical PLGNBIE scaffolds with 
varying porosities 
2. Confirming composition by electron dispersed x-ray analysis (EDX) 
3. Determining the mechanical strength of the scaffolds using an Instron device 
4. Determining the solubility of scaffolds in culture medium through electron 
dispersed x-ray analysis (EDX) and fourier transforming infrared analysis (FfIR) 
38 
MATERIALS AND METHODS 
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MATERIALS 
Cat. 
Material Manufacturer Number Area Formula 
Ethyl Alcholo USP Aaper Alcohol & Shelbyville , 
Absolute-200 Proof Chemical Co. 98L09QA KY NIA 
Dulbecco's Modified Gibco BRL Life Carlsbad , 
Eagle Medium Technology 11965-084 CA NIA 
F-12 Nutrient Mixture Gibco BRL Life Carlsbad, 
(HAM) Technology 11765-047 CA NIA 
Gibco BRL Life Carlsbad, 
Fetal Bovie Serum (FBS) Technology 16000-069 CA NIA 
Gibco BRL Life Carlsbad, 
Fungizone® Technology 15290-018 CA NIA 
Gibco BRL Life Carlsbad, 
Penicillin-Streptomycin Technology 15140-122 CA NIA 
85: 15 Poly (DL-lactic-co- Absorbable Polymers APT- Pelham, 
glycolide) Tech. 020402-1 AL NIA 
Boston, 
Iodized Salt Super Stop & Shop MA NaCl 
EQUIPMENT 
Item Manufactuer Model No. Area Description 
Scanning 
Scanning Electron Philips Eindhoven, Electron 
Microscope Electronics XL-20 NL Microscope 
High 
X-ray Analysis - Oxford Wycombe, 
INCA System Instruments England X-ray Analysis 
Instron Universal 
Testing Machine Instron Co. 4202 Canton, MA Instron 
50Ton 
Hydralic Press Enerpac Columbus , WI Hydralic Press 
Fourier Transforming 
Infrared FT-IR Avatar 360 Madison, WI FT-IR 
Degussa, Non-Vacuum 
Non-Vacuum Oven Vulcan 3-550 Dusseldorf Oven 
Barn Stead Non-Vacuum 
Non-Vacuum Oven Thermolyne 59300 Dubuque, IA Oven 
Gram-ATIC Balance Mettler Co. 1-90 Switzerland Balance 
Mettler PM 480 Mettler Co. PM480 Switzerland Balance 
Easy Pure RF 
Compact Ultrapure 
Water System Barn Stead D7031 Dubuque, IA Water Purifier 
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Nylon 0.02 & Fisher 
0.45mm Filter Scientific Pittsburgh , PA Filter, Sterilizer 
Precision Economy Precision Winchester, 
Incubator Scientific 5EM VA Incubator 
Water-Jacketed Forma 
Incubator Scientific Inc . 3158 Marietta, OH Incubator 
Wetzlar, 
DAS Mikroskop Leitz DMIL 090-131.002 Germany Microscope 
New 
Brunswick 
Scientific Co. 
Gyrotory® Shaker Inc. G2 Edison, NJ Shaker 
Tissue Culture 
Treated, 
Polystyrene, 
Costar 48 Well Cell Fisher Sterile , Non-
Culture Cluster Scientific 07-200-86 Pittsburgh, PA pyrogenic 
VWR West Chester, 
81 Slot Storage Box Scientific 55710-256 PA Storage Box 
Micro-
Centrifuge 
1.5 ml Micro- VWR West Chester, Tubes w/ 
Centrifuge Tubes Scientific 20170-378 PA Gradations 
VWR West Chester, USA Standard 
No. 70 Sieve Scientific PA Testing Sieve 
VWR West Chester, USA Standard 
No. 100 Sieve Scientific PA Testing Sieve 
VWR West Chester, USA Standard 
No. 200 Sieve Scientific PA Testing Sieve 
Commercial Blender Waring Blender 
Fisher 
1-200ul Redi-Tip Scientific 02-681-457 Pittsburgh , PA 1-200ul Tips 
Fisher 500-lOOOul 
500-lOOOul Redi-Tip Scientific 21-197-81 Pittsburgh , PA Tips 
Polypropylene, 
Disposable 
Sterile 
50ml Sterile Fisher Centrifuge 
Centrifuge Tubes Scientific 05-539-6 Pittsburgh, PA Tubes 
Polypropylene, 
Disposable 
Sterile 
15ml Sterile Fisher Centrifuge 
Centrifgue Tubes Scientific 05-539-2 Pittsburgh, PA Tubes 
Fisher Polystyrene , 
5ml Pipette Scientific 13-678-llD Pittsburgh, PA Disposable 
41 
Serological 
Pipette 
Polystyrene, 
Disposable 
Fisher Serological 
10ml Pipette Scientific 13-678-1 lE Pittsburgh, PA Pipette 
Polystyrene, 
Disposable 
Fisher Serological 
25ml Pipette Scientific 13-678-11 Pittsburgh, PA Pipette 
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METHODS 
Preparation of Bioactive Inorganic Element (BIE) 
BIE were ground using a commercial blender (Waring). The BIE particles were then 
sieved with a No. 100 and 200 sieves (VWR Scientific), collecting particles ranging in 
size from 7 5-150 µm. Particle sizes was confirmed through SEM analysis (Fig. 1) 
Fig. I: SEM image of BIE crystals show that they are between 75-150 µm. 
Preparation of PLGA 
PLGA pellets with a lactide/glycolide ratio of 85: 15 were obtained from Absorbable 
Polymer Technologies , Inc. (inherent viscosity, IV= 0.62 dUg). The PLGA has a glass 
transition temperature of 50-55°C and is completely flowable above 125°C according to 
the manufacturer. The pellets were ground using a commercial blender (Waring). Liquid 
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nitrogen was added to the blender to keep the PLGA from melting. The PLGA particles 
were then sieved with a No. 70 sieve (VWR Scientific), collecting particles less than 212 
µmin size 
Compositions of Scaff olds 
Bone tissue engineering involves the use of 3-dimensional scaffolds into which bone cells 
can be seeded to fabricate a bone matrix which can be implanted into a patient to 
regenerate bone at the defect site. Degradable polymers are ideal scaffold matrix because 
they provide mechanical strength when needed, allow for the timed release of bioactive 
molecules, and degrade when not needed, as when bone regenerates. The scaffold with 
the most amount of BIE, with the greatest amount of porosity for greater nutrient 
exchange, and with adequate mechanical strength would be the ideal matrix for bone 
regeneration. In this study, six different scaffolds with varying compositions of PLGA, 
BIE, and NaCl were investigated to determine the ideal concentrations of each 
component to achieve an ideal 3-dimensional scaffold matrix. 
Construction of Scaff olds 
Several methods have been described to create highly porous scaffolds. The method used 
to create a porous scaffold in this study utilized salt (Super Stop and Shop) as a water 
soluble porogen. The sizes of the NaCl particles range from 300-400 µm. This was 
confirmed through SEM analysis (Fig. 2). This size porosity is ideal for generation of 
osteogenesis because it allows for adequate exchange of nutrients and waste by the cells 
deep within the structure. In addition, when compared to different size pores, 300-400 
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um showed highest alkaline phosphatase activity and osteocalcin content (Tsuruga et al, 
1997). 
Ace V Spot M agn 
15 0 kV 4 0 34x 
Oet WO Exp 
SE 13 3 1 
500 µm 
Salt not ground 
Fig. 2: SEM image of NaCl crystals indicate sizes range from 300-400 µm. 
Six different compositions of PLGA, BIE, and salt were used in this study with varying 
porosities and BIE content according to volume percent (Table 1). From the known 
densities (p: BIE = 2.47, NaCl= 2.17, PLGA = 1.27) and volume percent desired, the 
exact weight of each component to include was calculate. The three components were 
mixed using a tumbler over night for no less than 12 hours in glass scintillation vials. 
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Composition NaCl BIE PLGA 
50% Porosity , 60:40 BIE:PLGA 50 % 30% 20% 
50% Porosity, 50:50 BIE:PLGA 50% 25 % 25 % 
50% Porosity , 40:60 BIE:PLGA 50% 20% 30% 
50% Porosity, 30:70 BIE:PLGA 50% 15 % 35 % 
60% Porosity, 50:50 BIE:PLGA 60% 20% 20% 
60% Porosity , 40:60 BIE:PLGA 60% 16 % 24% 
50% Porosity, 0: 100 BIE:PLGA 50% 0% 50% 
60% Porosity , 0: 100 BIE:PLGA 60% 0% 40% 
Table 1: Six different scaffolds constructed with varying porosities and B!E content 
according to volume % used in this study. Also included are negative controls that have 
0 % BIE. 
Cylindrical scaffolds 5.4 mm in diameter and 5 mm in height were made by a melt 
molding/particulate leaching technique. Approximately 0.2 g of PLGA/BIE/NaCl 
mixture were loaded into cylindrical 5 mm metal dies and placed in a mechanical 
convection oven (Thermolyne 8000) at 180°C for 10 minutes. At this temperature the 
PLGA is completely flowable as it is above the glass transition temperature . After ten 
minutes, the metal dies were then taken out and immediately compression molded using 3 
lbs of pressure . The scaffolds were then removed from the dies and weighed . 
The next step involved leaching of the porogen. The ·scaffolds were placed in a 1 L 
beaker with 500 mls of distilled water on a shaker (Gyrotory Shaker - G2) for 4 hours 
rotating at 150 rpms. The distilled water was replaced every hour. The scaffolds were 
then sterilized in 100% Ethanol for 3 min. After this time, the scaffolds were vacuum 
dried for 18 hours. The dried scaffolds were then weighed. 
Additionally, scaffolds were also viewed under SEM to observe the porosities (Figs. 4-
11) and an electron dispersed x-ray analysis (EDX) was done to ensure that there were no 
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more sodium and chlorine ions in the composition. This was done by bisecting one 
randomly selected scaffold from each composition group and gluing it onto a metal stub 
with the bisected side up. The sides of the scaffolds were then coated with silver paint. 
The scaffolds were then sputter coated with a film of gold alloy (Hummer II, Anatech, 
Springfield, VA). The scaffolds were then imaged under a high vacuum. Images were 
obtained using a Philips SL20 field emission SE microscope (Eindhover, NL) operating 
at 15 kV. EDX analysis was done using the INCA Systems software (Oxford 
Instruments, High Wycombe, England) at three different positions on each scaffold and 
the resulting values were averaged. 
Mechanical Strength Test 
Compressive strength of the scaffolds was tested using an Instron Universal Testing 
Machine, Model 4202 (lnstron Corp, Canton, MA). Rabbit bone was used as a control to 
compare the compressive strengths of the scaffolds. The femur bones of two Himalayan 
rabbits were collected and cleaned . The condyles of the femur bones were sectioned with 
a Stryker and cut into cylindrical pellets roughly 5 mm in diameter and 5 mm in height to 
match the size of our scaffolds. These bone pellets were stored in saline solution until 
further use. 
The bone samples were tested at a crosshead speed of 0.5 mm/min with a 10 kN cell. Six 
samples were tested and data was gathered. The average displacement value of 1.654 
mm was used a point of reference for subsequent tests. When testing the samples, the 
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Instron was set to stop compressive test at 1.654 mm and the load was determined. At 
least five scaffolds for each composition were tested. 
Solubility Test 
The samples consisted of six scaffolds per composition for each time period (3 days, 1 
wk, 2 wks, and 4 wks). In addition, two negative controls with 100 % PLGA were 
included, one with 50 % porosity and one with 60 % porosity. Sterile scaffolds were 
weighed and then placed in 48 well tissue culture plates (Fisher Scientific, Pittsburg, PA). 
The scaffolds were previously sterilized in 100 % ethanol for 3 minutes. Additionally, 
scaffolds were placed under UV light for 1 hour in tissue culture hood before adding 
culture medium. One ml of culture medium consisting of high glucose D-MEM/F-12 
(1:1), 10% (v/v) heat inactivated Fetal Bovine Serum (FBS), 200 U/ml penicillin, 50 
ug/ml Streptomycin, and 50 ug/ml Fungizone (GIBCO Invitrogen Corp, Carlsbad, CA) 
were placed in each well containing a single scaffold. Previous studies testing solubility 
of scaffolds used Simulated Body Fluid (Zhang et al., 2003). Culture medium was used 
in this study instead of Simulated Body Fluid because it contains essential proteins that 
reflect the conditions in the human body that are not found in Simulated Body Fluid. 
After addition of culture medium, plates were incubated at 37°C in a humidified 
atmosphere of 5 % CO2 in air for their respective time periods. Culture medium was 
collected in microcentrifuge tubes and replaced with 1 ml of fresh culture medium every 
3-4 days. Collected media was placed in -20°C freezer until needed for further analysis. 
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After their respective time periods, the plates containing the scaffolds were vacuum dried 
for no less than 24 hours. Once the scaffolds were completely dried, the final weights of 
the scaffolds were taken to determine how much of the scaffolds dissolved in the culture 
medium. Additionally, one scaffold from each group was analyzed using the electron 
dispersed x-ray analysis as was done before. 
Fourier Transform Infrared Spectroscopy (FTIR) 
The amount of Si-O bond in the culture medium was determined by using FfIR in a 
Nicolet Spectrometer Model Avatar 360 (Madison, WI). Peak assignments were based 
on previous studies (Filgueiras et al., 1993). Si-O spectra were obtained between 1148-
1070 cm-1 wavenumbers, with 2 cm-1 resolution. 
A standard curve was constructed using Ludox SK, a colloidal silica mixture (Grace 
Davison, Columbia, MD), which contains 25 % by weight of colloidal silica. Density of 
Ludox was determined to be 1.15 gm/ml. Since Ludox contains 25 % by weight of 
colloidal silica, it was determined that there was 289.5 mg silica/ml of Ludox. A curve 
was constructed through serial dilutions with culture medium plotting mg silica/ml 
against area in cm-1• 
Culture medium was collected and changed every three to four days and stored in -20 °C 
until needed for further analysis. At time of FfIR analysis, culture medium was thawed 
at room temperature. Each sample of culture medium was mixed on a lab vibrator for 3 
seconds before reading on the spectrophotometer. Fresh culture media was used as 
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background for all samples. Each reading was composed of 32 scans using 20 µl of 
collected medium. After each reading, area value was collected for each sample between 
wavenumbers 1148-1070 cm-1• After all samples were read, all area values were totaled 
for each sample . Since samples were collected twice a week, four week samples had 
eight values while three day samples only had one value. Then the total values for each 
sample of the control were subtracted from each sample of the tested composition. Once 
those values were totaled, the average and standard deviation of the six samples for each 
composition was taken. This area value was converted to mg silica/ml of solution using 
the Ludox SK standard curve . 
Next, electron dispersed x-ray analysis was done to determine the amount of silicon 
present on the scaffold surface. Scaffolds were prepared in the same manner as before. 
The weight percent silicon value obtained from the x-ray analysis was used to determine 
how much silicon remained in the scaffold. This was done by multiplying the weight 
percent by the weight of the scaffold and dividing by 100. This value was then 
multiplied by a 1000 to get a reading in milligrams. 
Statistical Analysis 
For the compressive strength data, statistical analysis was done using an ANOV A test to 
verify that the means of all compositions were not all equal. Then a tukey HSD test was 
done to individually compare the means of each composition to the control. A tukey 
HSD analysis was also done comparing the means of the control scaffold to the 
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experimental scaffolds for each time period . To determine if there was any significance 
in the amount of silicone lost from day O to day 3, 7, 14, or 28 days, a tukey HSD 
analysis was used. 
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RESULTS 
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RESULTS 
Scaff old Preparation 
In construction of porous scaffolds in this study, salt was used as a porogen to create the 
porosity. The success of this technique depends on whether or not all the salt has 
leached out of the scaffolds. 
To determine the absence of salt, the dry scaffolds were weighed before and after 
leaching. The weight percent of salt in the scaffolds was used to determine the expected 
weight loss from salt after leaching in water (MassNac1). From table 2, the data indicates 
that this is not a reliable method in determining absence of salt since the expected weight 
loss (MassNac1) did not match actual weight loss (MassA). To determine the actual 
amount of weight loss from salt (MassA), the final weight after leaching and drying 
(MassF) was subtracted from the initial weight before leaching (Mass,). 
Composition MassNae1 Weight % NaCl Massi (g) MassF (g) Masst. 
50% Porosity , 60 :40 BIE:PLGA 2.572 52.16 4 .931 2.531 2.4 
50% Porosity, 50:50 BIE:PLGA 2.591 53.71 4.824 2.231 2.593 
50% Porosity 40 :60 BIE:PLGA 2.618 55.36 4.729 2.645 2.084 
50% Porosity , 30:70 BIE :PLGA 2.684 57.11 4.699 2.691 2.008 
60% Porosity, 50:50 BIE:PLGA 3.028 63.51 4.768 2.057 2.711 
60% Porosity, 40:60 BIE:PLGA 2.969 65.03 4.566 1.462 3.104 
50% Porosity, 0: 100 BIE :PLGA 3.137 63.08 4.973 2.042 2.877 
60% Porosity , 0: 100 BIE :PLGA 3.538 71.93 4.919 1.322 3.597 
Table 2: MasSNaCl is expected mass of NaCl obtained by multiplying weight percent by 
initial mass (Massi) of 25 scaffolds for each composition . Masst1 reflects amount lost 
during leeching of scaffold by subtracting final mass (MassF) from initial mass (Massi), 
which should correspond to amount of NaCl lost. 
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Scanning electron microscope was used to visualize scaffolds under magnification for 
presence of porosities. The scaffolds were imaged under a high vacuum and images 
were obtained using a Philips SL20 field emission SE microscope (Eindhover, NL) 
operating at 15 kV. Images of the scaffolds were taken at 18x and 50x magnification. 
Figures 3 and 4 are images of the control samples, 50% Porosity, 0: 100 BIB:PLGA in 
figure 3 and 60% Porosity, 0: 100 BIB:PLGA in figure 4. The porosities in these controls 
were squarer because there was no BIB present. It was also evident that not all the salt 
has leached out of the samples. Figures 5-8 are images of samples with 50% Porosity, 
and varying amounts of BIB and PLGA. These samples all show some square porosities 
but the majority of the porosities are not uniformly square. This was due to the BIB 
particles. Figures 9 and 10 are images of samples with 60% porosities and varying 
amount of BIB and PLGA. They also show non-square porosities. Not surprisingly, they 
show more porosities than the samples in figures 5-8. However, this is purely 
observational and does not verify the degree of porosities in the samples in the scaffolds. 
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A 
B 
Fig. 3: SEM images of sample with 50% Porosity, 0:100 BIE:PLGA. A captured at 18x 
and B captured at 50x magnification. 
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Fig. 4: SEM images of sample with 60% Porosity, 0:100 BIE:PLGA. A captured at 18x 
and B captured at 50x magnification 
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Fig. 5: SEM images of sample with 50% Porosity, 60:40 BIE:PLGA. A captured at 18x 
and B captured at 50x magnification 
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Fig. 6: SEM images of sample with 50% Porosity, 50:50 BIE:PLGA. A captured at I Bx 
and B captured at 50x magnification 
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Fig. 7: SEM images of sample with 50% Porosity, 40:60 BIE:PLGA. A captured at /Bx 
and B captured at 50x magnification 
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Fig. 8: SEM images of sample with 50% Porosity, 30:70 BIE:PLGA. A captured at 18x 
and B captured at 50x magnification 
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Fig. 9: SEM images of sample with 60% Porosity, 40:60 BIE:PLGA. A captured at I Bx 
and B captured at 50x magnification 
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Fig. 10: SEM images of sample with 60% Porosity, 50:50 BIE:PLGA. A captured at 18x 
and B captured at 50x magnification 
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In this study, the absence of salt was confirmed using electron dispersed x-ray analysis of 
the scaffolds for their composition. Three different areas on each scaffold were tested 
and the values were averaged. Some graphs show minor amount of silver, aluminum, 
bromine , gold, and thorium. Silver was used to coat the sides of the scaffold. Gold was 
sputter coated on the samples . The presence of aluminum, bromine, and thorium could 
only be contributed to contamination during the processing for SEM imaging. Their 
values are still less than one weight percent. Figures 11 and 12 are graphs of the 
elemental constituents of the control samples 0: 100 BIE:PLGA (50% porosity in figure 
11 and 60% porosity in figure 12). The data showed that there was on BIE present due 
to the virtual absence of silicon. However, the graph for the sample with 50% Porosity 
0: 100 BIE:PLGA (figure 11) had an average of 6.24 weight percent of Cl and 6.1 weight 
percent of Na, confirming presence of salt. In the SEM images for scaffold 50% Porosity 
0: 100 BIE:PLGA (Figs. 3A and 3B), there clearly showed an area where there was no 
porosity. This area might have had residual salt particles and could be the reason there 
was a higher percentage of Na and Cl ions. 
Results of the analysis for scaffolds with 50:50 BIE:PLGA (50% porosity in figure 13 
and 60% porosity in figure 14) showed silicon with a weight percent of approximately 
10. In addition, there was less than one percent of Na or CL The graphs for scaffolds 
with 40:60 BIE:PLGA (50% porosity in figure 15 and 60% porosity in figure 16) also 
have less than one weight percent of Na and CL In figure 17, 50% porosity 30:70 
BIE:PLGA, the weight percent for Na was 1.84 and for Cl 1.42. This scaffold had a 
small amount of salt that did not completely leached out. The weight percent of silicon 
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for this sample was 7 .03 due to the decrease in BIE. Figure 18, scaffold 50% porosity 
60:40 BIE:PLGA had less than one weight percent of Na and Cl present. At 60% BIE, 
the weight percent of silicon went up to 11.74. 
Composition of Scaffold 50% Porosity, 0:100 
BIE:PLGA 
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Fig. 11: Average weight % data for EDX analysis sample 50% Porosity, 0: 100 
BIE:PLGA with standard deviation. 
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Composition of Scaffold 60 % Porosity, 0:100 
BIE:PLGA 
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Fig. 12: Average weight % data for EDX analysis of sample 60% Porosity, 0:100 
BIE:PLGA with standard deviation. 
Composition of Scaffold 50% Porosity, 50:50 
BIE:PLGA 
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Fig. 13: Average weight % data f or EDX analysis of sample 50% Porosity, 50:50 
BIE:PLGA with standard deviation. 
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Composition of Scaffold 60 % Porosity, 50:50 
BIE:PLGA 
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Fig. 14: Average weight % data for EDX analysis of sample 60% Porosity, 50:50 
BIE:PLGA with standard deviation. 
Composition of Scaffold 50 % Porosity, 40:60 
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Fig. 15: Average weight % data for EDX analysis of sample 50% Porosity, 40:60 
BIE:PLGA with standard deviation. 
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Composition of Scaffold 60% Porosity, 40:60 
BIE:PLGA 
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Fig. 16: Average weight % data for EDX analysis of sample 60% Porosity, 40:60 
BIE:PLGA with standard deviation. 
Composition of Scaffold 50% Porosity, 30:70 
BIE:PLGA 
60 ,-----------------------. 
Weight% 
50 <--- --+-------------------
30 
20 
0 
-10 C 0 Na Cl Si Ca Ag Au Br 
Fig. 17: Average weight % data for EDX analysis of sample 50% Porosity, 30:70 
BIE:PLGA with standard deviation. 
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Composition of Scaffold 50 % Porosity, 60:40 
BIE:PLGA 
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Fig. 18: Average weight % data for EDX analysis of sample 50% Porosity, 60:40 
BIE:PLGA with standard deviation. 
Compressive Strength Test 
Compressive strength test was done on an Instron Universal Testing Machine, Model 
4202 (lnstron Corp, Canton, MA). Bone samples from the femurs of rabbits were used as 
controls. The average maximal displacement before fracture for the control was 1.654 
mm. At this value, the mean for the maximal load of the bone was 0. 721 kN with a 
standard deviation of 0. 146 kN. For testing the samples, the Instron was set to stop 
compressing at a maximal displacement of 1.654 mm and the maximal load was 
recorded. At least five samples were tested for each composition. This value was used to 
compare the maximal loads of the samples to the bone control. 
From the data, aJJ samples tested except for 50% Porosity 30:70, 40:60 and 45:55 
BIE:PLGA had an average maximal load that was significantly lower than bone (Table 
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3). In addition, the means of the samples were not all equal when ANOV A was 
computed since the F value is significantly larger than the F critical value (20.3843 > 
2.0627) at a=0.05 level of significance . 
Anova: Single Factor 
SUMMARY 
Sample 
Groups size Sum Average Variance 
Bone 6 4.327 0.7211 0.0212 
50% Por, 30:70 BIE:PLGA 10 6.033 0.6033 0.0392 
50% Por, 40:60 BIE:PLGA 10 5.335 0.5335 0.0193 
50% Por, 45:55 BIE:PLGA 5 2.058 0.4116 0.0346 
50% Por, 50:50 BIE:PLGA 20 3.869 0.1934 0.0315 
50% Por, 55:45 BIE:PLGA 5 0.886 0.1772 0.0112 
50% Por, 60:40 BIE:PLGA 9 1.323 0.1470 0.0030 
60% Por, 40:60 BIE:PLGA 10 1.447 0.1447 0.0106 
60% Por, 50:50 BIE:PLGA 10 1.476 0.1476 0.0135 
ANOVA 
Source of Variation ss df MS F P-value F crit 
Between Groups 3.5598 8 0.4450 20.3843 4.28E-16 2.0627 
Within Groups 1.6590 76 0.0218 
Total 5.2188 84 
Table 3: ANOVA calculation for scaffolds tested in kN at 1.654 mm displacement using 
an Instron. 
Since it was determined that the means of the samples are not all equal, it was important 
to determine which sample lead to this difference. A tukey HSD test was done to 
determine if the means of each composition was statistically different from the control. 
At a significance level of a=0 .05, the p-value for all samples was statistically different 
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from bone for all scaffolds except 50% Porosity 30:70 BIE:PLGA, which had a p-value 
of 0.831 and 50% Porosity 40:60 BIE:PLGA, with a p-value of 0.268 (Table 4 ). 
Composition Mean (kN) p-value 
Bone 0.7211 -
50% Por, 30:70 BIE:PLGA 0.6033 0.831 
50% Por, 40:60 BIE:PLGA 0.5335 0.268 
50% Por, 45:55 BIE:PLGA 0.4116 0.024 
50% Por, 50:50 BIE:PLGA 0.1934 0.000 
50% Por, 55:45 BIE:PLGA 0.1772 0.000 
50% Por, 60:40 BIE:PLGA 0.1470 0.000 
60% Por, 40:60 BIE:PLGA 0.1447 0.000 
60% Por, 50:50 BIE:PLGA 0.1476 0.000 
Table 4: Compositions with mean maximal load (kN) and p-value for tukey HSD test for 
all samples tested. 
Solubility of the Scaffolds 
Solubility was tested by measuring the weight of the scaffold before and after incubation 
with culture medium. After scaffolds were prepared, they were weighed to determine the 
initial weight. They were then sterilized under UV light for 1 hour before addition of 
culture medium. Six samples were tested for each composition at each time period. 
After their respective time periods and removal of culture medium, the samples were 
vacuum dried for no less than 24 hours. After this period, the scaffolds were weighed 
again to determine their final weight. To determine the weight loss, the final weight of 
each scaffold was subtracted from their initial weight. The mean and standard deviation 
was calculated for each composition (Table 5). Data of solubility over time was graphed 
(Figs. 19, 20). 
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50%P, 50% P, 50%P, 50%P, 50%P, 60%P, 60%P, 
0:100 30:70 40:60 50:50 60:40 0:100 50:50 
0.056 0.029 0.013 0.007 0.024 0.047 0.009 
3da s 0.008 0.013 .0005 .004 0.013 0.009 0.008 
0.07 0.05 0.029 0.012 0.012 0.051 0.029 
7da s 0.007 0.021 0.014 .006 0.005 0.014 0.016 
0.034 0.026 0.024 0.016 0.035 0.004 0.017 
14 da s 0.021 0.008 0.013 .016 0.012 0.003 0.015 
0.013 0.043 0.039 0.01 0.013 0.022 0.03 
28da s 0.005 0.019 0.014 0.01 0.01 0.007 0.011 
Table 5: Values are average mass loss (g) of six samples from our 8 different 
compositions with standard deviation in parenthesis. 
Average Mass loss for Scaffolds in Culture Medium 
0.09 .-------------------~-..... 
0.08 - t-----------------------j 
0.07 - i-------- ~ ---------- -----j 
0.06 -·i--- --;--~ ~--i--- .....- --------;--------1 
t:)!) 0.05 - i------t-------,: ~ ----'sc-----lt------+----t 
e 0.04 -·t---t-----,.-------- "<--t- ----or~---1 
0.03 -i---- -¥- ------:';--- ~ -+----'9l<:"-·---+----l 
0.02 -l--- -+- __:::,.--=---- ------~-- +-- -- --- - 1----1 
0.01 
0 -+--- --- ~ ---- ~ - ~ --~ - ~ ------1 
3 days 7 days 14 days 28 days 
60:40 BIE:PLGA 
- 50:50 BIE:PLGA 
40:60 BIE:PLGA 
-4( 30:70 BIE:PLGA 
0:100 BIE:PLGA I 
Fig 19: Graph of solubility of scaffolds over time with standard deviation for 50% 
porosity series. 
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Fig 20: Graph of solubility of scaffolds over time with standard deviation for 60% 
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Fourier transforming infrared (FITR) analysis was used to compare the proportion of the 
Si released in releation to the different compositions from culture medium. Peak 
assignments were based on previous studies (Filgueiras et al., 1993) . Si-OH spectra were 
obtained between 1148-1070 cm-1 wavenumbers, with 2 cm-1 resolution. Culture medium 
was collected every 3-4 days in microcentrifuge tubes and placed in -20°C till need for 
analysis. 
A standard curve was constructed usmg Ludox SK. This colloidal silica mixture 
contained 25% by weight of colloidal silica. Density of Ludox was determined to be 1.15 
gm/ml. Since Ludox contained 25% by weight of colloidal silica, there was 289.5 mg 
silica per ml of Ludox. Serial dilutions were made using culture medium to dilute the 
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Ludox (Table 6). A curve was constructed through serial dilutions with culture medium 
plotting mg silica/ml against area in cm-1 (Fig. 21). 
area mg/ml Si-OH dilution 
9.920 289.5 1:01 
5.117 144.7 1:02 
2.826 72.37 1:04 
1.116 36.2 1:08 
0.607 18.1 1: 16 
0.319 9.05 1:32 
0.097 4.52 1:64 
Table 6: Area indicates value underneath peak 1148-1070 cm-1 wavenumbers for Ludox 
dilutions and corresponding concentration of Si-OH. 
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Data for the area underneath 1148-1070 cm-1 wavenumbers was gathered for all culture 
medium samples (1 reading for three days, 2 readings for 7 days, 4 readings for 14 days, 
and 8 readings for 28 days). The values obtained from the control samples (50% 0: 100, 
60% 0: 100 BIE:PLGA) were subtracted from the testing samples (50% Porosity: 60:40, 
50:50, 40:60, 30:70 BIE:PLGA, 60% Porosity: 50:50, 40:60 BIE:PLGA). The average 
and standard deviation was obtained for the six samples in each time period for each 
composition. 
The data gathered from the FfIR analysis was converted to mg/ml Si-OH using the 
Ludox SK standard curve (Tables 7-10). To determine if the means of each composition 
was statistically different from the control, a tukey HSD test was done and the p value 
included in tables 7-10. All compositions for all time periods show statistically different 
means from control except for samples 50% Porosity 30:70 and 40:60 BIE:PLGA at day 
three. A graph was constructed plotting mg/ml Si-OH released over time (Figs. 22, 23). 
This data can only be used to compare the proportion of silicon released from one 
composition to another. 
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3d ays 
composition n mean area mg/ml SiOH p 
50% 0: 100 BIE:PLGA 6 0 - -
50% 30:70 BIE:PLGA 6 0.109 4.82 0.177 
50% 40:60 BIE:PLGA 6 0.108 4.82 0.187 
50% 50:50 BIE:PLGA 6 0.148 5.547 0.034 
50% 60:40 BIE:PLGA 6 0.186 6.06 0.005 
60% 0: 100 BIE :PLGA 6 0 - -
60% 40:60 BIE:PLGA 6 0.162 5.73 0.012 
60% 50:50 BIE:PLGA 6 0.132 5.44 0.04 
Table 7: Data conversions of mean area obtained from FTIR analysis to mg/ml Si-OH 
using Ludox SK standard curve for day 3 samples. Also included is P value from Tukey 
HSD analysis at a=0.05. 
7d ays 
composition n mean area mg/ml SiOH p 
50% 0:100 BIE:PLGA 6 0 - -
50% 30:70 BIE:PLGA 6 0.268 7.84 0.011 
50% 40 :60 BIE:PLGA 6 0.373 10.46 0 
50% 50:50 BIE:PLGA 6 0.298 8.34 0.004 
50% 60:40 BIE:PLGA 6 0.256 7.81 0.016 
60% 0: 100 BIE:PLGA 6 0 - -
60% 40:60 BIE:PLGA 6 0.259 7.81 0.001 
60% 50:50 BIE:PLGA 6 0.336 9.45 0 
Table 8: Data conversions of mean area obtained from FTIR analysis to mg/ml Si-OH 
using Ludox SK standard curve for day 7 samples. Also included is P value from Tukey 
HSD analysis at a=0.05. 
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14 d ays 
composition n mean area mg/ml SiOH p 
50% 0: 100 BIE:PLGA 6 0 - -
50% 30:70 BIE:PLGA 6 0.476 13.57 0.001 
50% 40:60 BIE:PLGA 6 0.532 15.69 0 
50% 50:50 BIE:PLGA 6 0.425 12.27 0.002 
50% 60:40 BIE:PLGA 6 0.538 15.69 0 
60% 0: 100 BIE:PLGA 6 0 - -
60% 40:60 BIE:PLGA 6 0.662 20.11 0 
60% 50:50 BIE:PLGA 6 0.555 16.09 0 
Table 9: Data conversions of mean area obtained from FTIR analysis to mg/ml Si-OH 
using Ludox SK standard curve for day 14 samples. Also included is P value from Tukey 
HSD analysis at a=0.05. 
28 d ays 
composition n mean area mg/ml SiOH p 
50% 0:100 BIE:PLGA 6 0 - -
50% 30 :70 BIE:PLGA 6 1.047 32.58 0 
50% 40:60 BIE:PLGA 6 0.754 23.33 0 
50% 50:50 BIE:PLGA 6 1.088 32.49 0 
50% 60:40 BIE:PLGA 6 1.13 36.2 0 
60% 0:100 BIE:PLGA 6 0 - -
60% 40:60 BIE:PLGA 6 1.42 32.58 0 
60% 50:50 BIE:PLGA 6 1.326 41.03 0 
Table 10: Data conversions of mean area obtained from FTIR analysis to mg/ml Si-OH 
using Ludox SK standard curve for day 28 samples. Also included is P value from Tukey 
HSD analysis at a=0.05. 
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The percent silico n value gathered from the electron dispersed x-ray analysis of dried 
scaffolds was used to determine how much silicon remained in the scaffolds after 3, 7, 
14, and 28 days . P values indicate whether or not there is a statistically significant 
difference between silicon value between day 0 and day 3, 7, 14, or 28. 
day s mean SI lost n p 
0 0.273 0 3 -
3 0 .236 -13.5 3 0.724 
7 0.273 0 3 1 
14 0.286 +4.7 3 0.99 
28 0.24 -12.1 3 0.784 
Table 11: Weight of silicon in mg at different time periods and amount of silicone lost in 
culture medium for composition 50% porosity, 0: JOO BIE:PLGA. Also included is P 
value from Tukey HSD analysis at o.=0.05. 
days mean SI lost n p 
0 7.52 0 3 -
3 8.92 +18.6 3 0.413 
7 4.9 -34.8 3 .042* 
14 4.18 -44.4 3 .01 * 
28 3.29 -56.2 3 .002 * 
Table 12: Weight of silicon in mg at different time periods and amount of silicone lost in 
culture medium for composition 50% porosity, 30:70 BIE:PLGA. Also included is P 
value from Tukey HSD analysis at o.=0.05. * denotes that there is statistically significant 
difference to control (day 0). 
days mean SI lost n p 
0 8.93 0 3 -
3 8.34 -6.6 3 0.919 
7 9.92 +11.0 3 0 .663 
14 10.55 +18.1 3 0.241 
28 8.27 -7.9 3 0.887 
Table 13: Weight of silicon in mg at different time periods and amount of silicone lost in 
culture medium for composition 50% porosity, 40:60 BIE:PLGA. Also included is P 
value from Tukey HSD analysis at o.=0.05. 
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days mean SI lost n p 
0 9.96 0 3 -
3 6.16 -38.1 3 0.091 
7 5.38 -45.9 3 0.036* 
14 4.81 -51.7 3 0.018* 
28 4.32 -56.6 3 0.01 * 
Table 14: Weight of silicon in mg at different time periods and amount of silicone lost in 
culture medium for composition 50% porosity, 50:50 BIE:PLGA. Also included is P 
value from Tukey HSD analysis at a=0.05. * denotes that there is statistically significant 
difference to control (day 0). 
days mean SI lost n p 
0 11.62 0 3 -
3 9.55 -17.8 3 0.271 
7 8.42 -27.5 3 0.047 * 
14 10.96 -5.7 3 0.956 
28 9.84 -15.3 3 0.396 
Table 15: Weight of silicon in mg at different time periods and amount of silicone lost in 
culture medium for composition 50% porosity, 60:40 BIE:PLGA. Also included is P 
value from Tukey HSD analysis at a=0.05. * denotes that there is statistically significant 
differen ce to control ( day 0 ). 
days mean SI lost n p 
0 8.77 0 3 -
3 7.12 -18.8 3 0.387 
7 6.65 -24.2 3 0.19 
14 5.99 -31.7 3 0.061 
28 4.92 -43 .9 3 .01 * 
Table 16: Weight of silicon in mg at different time periods and amount of silicone lost in 
culture medium for composition 60% porosity , 40:60 BIE:PLGA. Also included is P 
value from Tukey HSD analysis at a=0.05. * denotes that there is statistically significant 
difference to control (day 0). 
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days mean SI lost n p 
0 7.52 0 3 -
3 4.73 -37.1 3 0.15 
7 4.08 -45.7 3 0.061 
14 7.71 +2.5 3 1 
28 6.02 -19.9 3 0.671 
Table 17: Weight of silicon in mg at different time periods and amount of silicone lost in 
culture medium for composition 60% porosity, 50:50 BIE:PLGA. Also included is P 
value from Tukey HSD analysis at a=0.05 . 
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Scaff old Preparation 
The first objective of this study was to prepare scaffolds with different compositions of 
PLGA and BIE at 50% and 60% porosities. The PLGA was used to provide mechanical 
strength to the scaffold and the BIE was included to stimulate osteogenesis. Previous 
studies have suggested that the composition of BIE may influence its osteogenic activity 
(Al-bazie et al., 1998; Chou et al., 1998). Bioactivity is associated with certain 
compositional range of SiO2, Na2O, CaO, and P2O5• The surface of the BIE can be 
highly reactive when exposed to an aqueous medium when there is high Na2O and CaO 
content, <60 mo!% SiO2, and high CaO:P2O5. This surface could form a biologically 
active hydroxycarbonate apatite (HCA) layer (Hench LL, 1998). 
The scaffolds used m this study was developed usmg the melt molding/particulate 
leaching technique. The temperature setting during melt molding was adequate for 
fabrication of scaffolds because it was above the glass transition temperature (Tg) of 
PLGA (Tg of PLGA= 50-55 °C). In addition, the compression of our scaffolds at 3 lbs of 
pressure yielded scaffolds that were consistently 5.4 mm in diameter and 5 mm in height. 
The second process in making porous scaffolds was to create porosities in the scaffolds. 
Developing scaffolds with sufficient porosity was critical in producing a material that can 
be used for bone tissue engineering. Porosity provides space for the cells to infiltrate the 
scaffolds and also allows blood vessels to ingress. In addition, the pores allows for 
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inflow of nutrients and elimination of metabolic waste and biodegradation by products 
(Agrawal et al., 2000). Developing scaffolds with pores was done by incorporating salt 
particles into the composition and then leaching the salt in water after the scaffolds had 
been melt molded. The leaching step involved placing the scaffolds in a 1 liter beaker 
with 500 mls of distilled water. The beaker was rocked on a shaker at 150 rpms for 4 
hours. In addition , the water was changed every 1 hour. After 4 hours, the scaffolds 
were vacuum dried overnight. Even though at this point, the scaffolds were ready for 
testing, it was important to confirm the absence of all salt particles. Therefore the second 
objective of the study was to confirm presence of porosities in the scaffolds and the 
composition of the scaffolds. 
SEM analysis was used to test the presence of porosities. However, this was purely 
observational and did not confirm that the salt had leached from the scaffolds. From the 
SEM images, it was evident in some samples that the porosity was not evenly distributed 
throughout the scaffold. In figure 3A (pg. 55), there was an area close to the lower left 
comer in the scaffold where there was less porosity. This could be a critical concern 
when developing ideal scaffolds because the channels created in the scaffolds increase 
cell and tissue penetration. Remember that porosities are intended to allow for 
development of vascular tissue by the in growth of granulation tissue from the host. The 
increase in vascularization in the scaffold allows for more transport of nutrients which is 
essential to the developing tissue (Tsuruga et al., 1997). This problem could be due to 
uneven distribution when mixing the different components of the scaffold. However, all 
compositions were mixed overnight which should allow for even distribution of our 
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compositions. For future studies it would be good to evaluate porosity of scaffolds using 
mercury posoimetry. This technique would give insight into degree of porosity and pore 
size. 
Electron dispersed x-ray analysis was used in this study to test the chemical composition 
of the scaffolds . From the data, all scaffolds showed complete absence of salt except for 
sample 50% Porosity 0: 100 BIE:PLGA (fig. 11, page 64 ). This could be due to the fact 
that there was too much PLGA in the scaffold which caused the crystals to surround the 
salt particles, thus preventing dissolution of the salt. Another possibility could be that 
there was inadequate mixing of the components of the scaffold. However all 
compositions were mixed equally. A final possibility could be that the scaffold with this 
amount of PLGA needed to be leached for a longer period of time. Future investigators 
should consider these possibilities when developing their scaffolds. 
The electron dispersed x-ray data also showed that average weight percent of silicon for 
both 50% and 60% porosity increased as the amount of BIE increased. This was 
expected since silicon is a component of BIE. The data indicate that the weight percent 
of silicon for 60% BIE was 11.74% (Figure 18, page 68), weight percent of silicon for 
50% BIE was 10.19% (Figure 13, page 65), weight percent of silicon for 40% BIE was 
8.94% (Figure 15, page 66), and weight percent of silicon for 30% BIE was 7.03% 
(Figure 17, page 67) in 50% porosity series. For the 60% porosity series, the weight 
percent of silicon for 50% BIE was 10.49% (Figure 14, page 66) and the weight percent 
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of silicon for 40% BIE was 11.88% (Figure 16, page 67). These values were not 
statistical! y significant. 
Compressive Strength of the Scaffolds 
The second objective of this study was to test the strength of the scaffolds using an 
Instron machine. It is important for scaffolds to have adequate strength to support 
mastication and other such forces. Lu et al found that the addition of bioactive glass 
granules to the PLGA mixture resulted in a structure with higher compressive modulus 
than PLGA alone. They also found that PLGA-bioactive glass composite formed a 
surface calcium phosphate deposits in simulated body fluid. PLGA was incorporated in 
this study to provide the strength needed to support the scaffolds. Additionally, the 
degradation rate of the polymer could be manipulated to match the rate of bone 
formation. 
The compressive strength of the scaffolds was tested using an Instron machine. Rabbit 
femur bone was used as a control to determine the compressive strength needed for the 
scaffolds. The results reveal that comparable strength to the rabbit bone could be 
achieved by developing scaffolds with at least 60 % PLGA by weight (p = 0.268). 
Additionally, all of the scaffolds that were tested with 60 % porosity did not have enough 
strength (p = 0.00) . The results indicated that the least amount of porosity that would 
give comparable compressive strength to bone was 50 %. 
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Solubility of the Scaffolds 
The final objective of this study was to determine the amount of silicon release from the 
scaffolds. Previous studies have reported that soluble silicon can be used to regulate 
growth factor proteins and enhance bone growth (Xynos, I.D. et al., 2000). It is released 
by both ion exchange and network dissolution. It has been shown that soluble silicon can 
be used to regulate growth factor proteins and enhance bone growth (Xynos, I.D. et al., 
2000). 
BIE has a composition including SiO2, Na2O, CaO, and P2O5 • Bioactive glasses such as 
BIE have been shown to be osteoinductive. It can bond to living bone. This bond has 
been related to the formation of a biologically active hydroxycarbonate apatite layer 
(HCA) on the surface of the glasses. There are 12 stages of interfacial reactions involved 
in forming the bond between tissue and bioactive glass (Hench, L.L., 1993). Silanol (Si-
OH) can be found during this reaction and is an integral part of the formation of the HCA 
layer. 
Filgueiras et al showed that bioactive glass forms a HCA layer in simulated body fluid by 
measuring levels of Si-OH bond using Fourier Transforming Infrared analysis (Filgueiras 
et al., 1993). Peak assignments for this study were based on their study. 
The result of the FTIR analysis showed that dissolution of the scaffold lead to an increase 
in Si-OH bond over time. Since the FTIR analysis only measured Si-OH bond, the 
results could only be used to compare the proportion of silicon released from one 
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(p=0.413). By day 7, 34.8 mg (p=0.042) of silicon was released into the culture medium 
and by day 28, 56.2 mg (p=0 .002) of silicon was released. 
Similar results were obtained for composition 50% porosity and 50:50 BIE:PLGA (table 
14, pg. 76). At day 3 there was no statistically significant difference in silicon release 
than at day 0. By day 7, 38.1 mg (p=0 .036) of silicon was dissolved from the scaffold 
and by day 28, 56.6 mg (p=0 .01) of silicon was dissolved. This increase silicon could be 
important for bone cell growth. Xyos et al found that soluble silicon released through ion 
exchange and network dissolution could be used by cells to regulate growth factor 
proteins and enhance bone growth. 
All other compositions showed variable results with no significant difference between 
silicon release at day 0 and day 28 (compositions 50% porosity 40:60 and 60:40 
BIE:PLGA and 60% porosity 50 :50 BIE:PLGA). However, composition 60% porosity 
40 :60 BIE:PLGA showed significant difference in silicon release at day 28 (p=0 .01) but 
no difference at day 3, 7 or 14. 
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exchange and network dissolution could be used by cells to regulate growth factor 
proteins and enhance bone growth. 
All other compositions showed variable results with no significant difference between 
silicon release at day 0 and day 28 (compositions 50% porosity 40:60 and 60:40 
BIE:PLGA and 60% porosity 50:50 BIE:PLGA). However, composition 60% porosity 
40:60 BIE:PLGA showed significant difference in silicon release at day 28 (p=0.01) but 
no difference at day 3, 7 or 14. 
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CONCLUSIONS 
89 
CONCLUSIONS 
I . Compressive strength of scaffolds comparable to rabbit bone mass was achieved by 
constructing scaffolds with at least 60% poly(DL-lactic-co-glycolic acid) by weight 
and with no more than 50% porosity. 
2. Scaffolds with greater amount of bioactive inorganic element release more silicon as 
measured by Si-OH bond compared to scaffolds with less bioactive inorganic 
element. 
3. Scaffolds with 50% porosity and 30% bioactive inorganic element had 56.2 mg of 
silicon released into culture medium by 28 days while scaffolds with 50% porosity 
and 50% bioactive inorganic element had up to 56.6 mg of silicon released into 
culture medium by 28 days. 
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FUTURE STUDIES 
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FUTURE STUDIES 
This study provided insights into the possibility of implanting PLGA/BIE scaffolds for 
tissue engineering and bone regeneration. Additional studies would be necessary to 
evaluate in vitro seeding of human osteoblast cells into the PLGA/BIE scaffolds. In vivo 
implantation of cell seeded scaffolds into animal or human subjects would provide 
valuable information on the result of using PLGA/BIE scaffolds for tissue regeneration. 
Future investigation into developing a scaffold made only of BIE, but with adequate 
strength, would eliminate the inflammatory effects of PLGA. 
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